Hero

About Us


Get to know more about our company

Doctor microscope

homepage.text19

Regenic is Indonesia's first cGMP-certified stem cell manufacturing facility, dedicated to advancing healthcare through innovative stem cell and secretome therapies. With state-of-the-art technology and a commitment to quality, safety, and ethics, we develop solutions for orthopedic conditions, chronic diseases, and more. Collaborating with hospitals and institutions, Regenic is driving the future of regenerative medicine, offering hope and new possibilities for improved health and quality of life.

10+

years of RnD in cellular therapy

Scope of Business

text22
Research and Development Centre for innovative cell therapy products
text23
Education centre for stem cell
text24
Stem cell processing for autologous purposes
text25
GMP manufacturing of allogenic stem cell & its derivatives

Vision & Mission

Headquartered at the Kalbe Business Innovation Centre (KBIC) in Jakarta, Regenic was founded in 2013 as a stem cell manufacturing and education center under PT Bifarma Adiluhung, a subsidiary of PT Kalbe Farma, Tbk. Regenic holds the distinction of being the first in Indonesia to achieve GMP certification from BPOM and an Operating License from the Ministry of Health (Kementerian Kesehatan), enabling us to manufacture clinical-grade stem cells and their metabolites products

Vision

As Indonesia's premier stem cell manufacturing facility, we adhere to world-class standards, offering new hope to patients with unmet medical needs

Mission

We are dedicated to produce and deliver high-quality cell therapy products with integrity, prioritizing patient well-being and safety

Understanding Our Approach

We believe in harnessing the power of cutting-edge regenerative medicine to provide personalized cell therapy treatments. Our approach is guided by a commitment to patient-centered care, scientific innovation, and proven therapeutic techniques. Here's how we do it:

Our Approach

STEP 1

Consultation with Our Partner Providers

STEP 2

State-of-the-Art Regenerative Treatments

STEP 3

Safety and Efficacy

STEP 4

Ongoing Monitoring and Support

Qualifications and Recognitions

Qualification
Qualification
Qualification
Qualification
Qualification

Team of
Compassionate Experts

dr Sandy Qlintang M.Biomed

dr Sandy Qlintang M.Biomed

President Director

Harry Murti

Harry Murti

Head of Manufacturing

Jimmy Susanto

Jimmy Susanto

Director